Skip to main content
Caplight Logo









Fluid Biomed

Fluid Biomed

Private
CalgaryHealthcare & Life Scienceshttps://fluidbiomed.com/

Last Round

Series A

Dec 16, 2024

Total Funding Raised

$59.55M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Fluid Biomed is a medical device company that develops a bioabsorbable, polymer-based stent called ReSolv™ to treat brain aneurysms.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

bioresorbable stentvascular stentcardiovascular implantdissolvable stentmedical deviceinterventional cardiologyaneurysm treatmentflow-diverting stentmedtechvascular surgerybiomaterialsclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fluid Biomed Comparables

Compare Fluid Biomed with similar companies based on industry and business-model similarity.

Fluid Biomed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Amaranth Medical, Inc.
87%
Elixir Medical Corporation
86%
REVA Medical
86%

Fluid Biomed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 16, 2024
Series ANov 1, 2024
SeedAug 11, 2021
Pre SeedFeb 1, 2020

Fluid Biomed Investors

Notable investors and investment history

Fluid Biomed investors
InvestorRounds
IAG Capital PartnersSeries A
Wharton Alumni AngelsSeed
Amplitude VenturesSeries A
Amino CapitalSeed
LifeArc VenturesSeries A
ShangBay CapitalSeries A, Seed
Innovate CalgarySeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 10, 2.5x the trailing average.

  • Jul 13, 2026

    Open roles increased from 0 to 8, representing 22% of headcount.

Fluid Biomed Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fluid Biomed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fluid Biomed's valuation, stock price, and market status.

Firmographic Details

HeadquartersCalgary
Employee Range36
Year Founded2012
Last FundingDec 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?